PATEL PRITI (Chief Medical Officer) sold 31.6% of their position (14.38K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $8.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/3/2023ACC: 0001209191-23-006881
Officer· Chief Medical Officer
Since Apr 2021
-14.38K
Net shares
Net seller
$8.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
35K acquired · 49.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
334.5%
2/1/2023
10.46K→45.46K
Common Stock
Direct
Shares
−14.38K
Price / share
$0.60
Trade value
$8.59K
% of position
31.6%
2/2/2023
45.46K→31.08K
Total
Net shares
+20.62K
Net value
-$8.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | M · Option Exercise | +35K | — | — | 334.5% | 10.46K | 45.46K |
| Common Stock Direct | 2/2/2023 | S · Sale | −14.38K | $0.60 | $8.59K | 31.6% | 45.46K | 31.08K |
| Total | +20.62K | -$8.59K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
35K shares
Shares
−35K
Strike price
0.00
Held after
35K
Exercisable
—
2/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock35K shares | 2/1/2023 | M · Option Exercise | −35K | 0.00 | — | 35K |